Dascena
Dascena's COViage system uses demographic and vital-sign data pulled from a COVID-19 patients' EHR to calculate their risk of hemodynamic instability or respiratory failure.
Also: Dascena closes $50 million for diagnostic algorithms; Scopio Labs collects $16 million Series B to expand digital microscopy business.